bharat biotech

India has left the US behind by crossing the million mark in just six days as compared to nine days taken by the US.

The prestigious medical journal said that Covaxin generated tolerable safety outcomes and enhanced immune responses.

India has not sent any vaccines to Pakistan, and there are no reports suggesting that Indian govt will send any vaccine to them

Earlier, Covaxin was approved for children above 12, while SII's Covishield was approved for persons above 18. The new order states that Covaxin will also be administered only to persons above 18.

Covishield vaccine produced by the Seru Institute of India to be available at Rs 200 per dose.

The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin

The vaccination will start after the forthcoming festivals across the country including Lohri, Makar Sankranti, Pongal, Magh Bihu etc

For a country this size with the massive population as well as innumerable hurdles, India has indeed done a tremendous job in containing coronavirus pandemic.

The Indian regulatory body has approved emergency use of both Serum Institute developed Covishield and Bharat Biotech's Covaxin to combat the coronavirus

Dr Gangandeep Kang was one of the 150 'scientists' who signed a letter indirectly asking the voters to vote against PM Modi in 2019.